Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

464

HTML

4646

Figures (1-4)

289

Tables (1-12)

284

Sum=5683

May 14, 2009 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlights

World J Gastroenterol. May 14, 2009; 15(18): 2190-2203
Published online May 14, 2009. doi: 10.3748/wjg.15.2190

Table 2 Pros and Cons of liver biopsy in staging of hepatic fibrosis

PROS	CONS
Staging of liver fibrosis	Invasiveness (pain, bleeding)
Grade of necroinflammation	Cost (hospitalization)
Steatosis (common in hepatitis C)	Sampling errors
Iron overload (common in hepatitis C)	Possibly refused by patient, concern of physician
Comorbidities (autoimmunity stigmates)	Static data, no information on fibrogenesis

Citation: Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203
URL: https://www.wjgnet.com/1007-9327/full/v15/i18/2190.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2190